Alenka Matjasic

Ms. Alenka Matjasic


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2021 in Cancers
Verified
Journal Article
Open access
PDF file
Maksim SorokinMaksim Sorokin
Maksim Sorokin
Michael RaevskyMichael Raevsky
Michael Raevsky
AZAlja Zottel
Alja Zottel
NŠNeja Šamec
Neja Šamec
MVMarija Skoblar Vidmar
Marija Skoblar Vidmar
Ivana JovcevskaIvana Jovcevska
Ivana Jovcevska
Glioblastoma is the most common and malignant brain malignancy worldwide, with a 10-year survival of only 0.7%. Aggressive multimodal treatment is not enough to increase life expectancy and provide good quality of life for glioblastoma patients. In addition, despite decades of research, there are no established biomarkers for early disease diagnosis and monitoring of patient response to treatment. High throughput sequencing technologies allow for the identification of unique molecules from large clinically annotated datasets. Thus, the aim of our study was to identify significant molecular changes between short- and long-term glioblastoma survivors by transcriptome RNA sequencing profiling, followed by differential pathway-activation-level analysis. We used data from the publicly available repositories The Cancer Genome Atlas (TCGA; number of annotated cases = 135) and Chinese Glioma Genome Atlas (CGGA; number of annotated cases = 218), and experimental clinically annotated glioblastoma tissue samples from the Institute of Pathology, Faculty of Medicine in Ljubljana corresponding to 2–58 months overall survival (n = 16). We found one differential gene for long noncoding RNA CRNDE whose overexpression showed correlation to poor patient OS. Moreover, we identified overlapping sets of congruently regulated differential genes involved in cell growth, division, and migration, structure and dynamics of extracellular matrix, DNA methylation, and regulation through noncoding RNAs. Gene ontology analysis can provide additional information about the function of protein- and nonprotein-coding genes of interest and the processes in which they are involved. In the future, this can shape the design of more targeted therapeutic approaches.

27 August 2019 in Brain Pathology
Verified
Journal Article
Closed access
AMAlenka Matjasic
Alenka Matjasic
AZAndrej Zupan
Andrej Zupan
EBEmanuela Boštjančič
Emanuela Boštjančič
JPJože Pižem
Jože Pižem
MPMara Popović
Mara Popović
DKDanijela Kolenc
Danijela Kolenc

6 January 2021 in Virchows Archiv
Verified
Journal Article
Closed access
PDF file
KSKlemen Stražar
Klemen Stražar
DŠDaja Šekoranja
Daja Šekoranja
AMAlenka Matjasic
Alenka Matjasic
AZAndrej Zupan
Andrej Zupan
ŽSŽiga Snoj
Žiga Snoj
JPJoze Pizem
Joze Pizem

20 November 2020 in Genes
Verified
Journal Article
Open access
PDF file
AZAndrej Zupan
Andrej Zupan
AMAlenka Matjasic
Alenka Matjasic
GGGašper Grubelnik
Gašper Grubelnik
Velibor TasicVelibor Tasic
Velibor Tasic
AMAna Momirovska
Ana Momirovska
Genetic studies of population isolates have great potential to provide a unique insight into genetic differentiation and phenotypic expressions. Galičnik village is a population isolate located in the northwest region of the Republic of North Macedonia, established around the 10th century. Alport syndrome-linked nephropathy with a complex inheritance pattern has been described historically among individuals in the village. In order to determine the genetic basis of the nephropathies and to characterize the genetic structure of the population, 23 samples were genotyped using a custom-made next generation sequencing panel and 111 samples using population genetic markers. We compared the newly obtained population data with fifteen European population data sets. NGS analysis revealed four different mutations in three different collagen genes in twelve individuals within the Galičnik population. The genetic isolation and small effective population size of Galičnik village have resulted in a high level of genomic homogeneity, with domination of R1a-M458 and R1b-U106* haplogroups. The study explains complex autosomal in cis digenic and X-linked inheritance patterns of nephropathy in the isolated population of Galičnik and describes the first case of Alport syndrome family with three different collagen gene mutations.

7 November 2024 in Journal of Cutaneous Pathology
Verified
Journal Article
Open access
DŠDaja Šekoranja
Daja Šekoranja
AZAndrej Zupan
Andrej Zupan
AMAlenka Matjasic
Alenka Matjasic
EBEmanuela Bostjancic
Emanuela Bostjancic
ECEduardo Calonje
Eduardo Calonje
JPJoze Pizem
Joze Pizem
Background: There is growing evidence that the Spitz group of melanocytic neoplasms should be restricted to those harboring kinase receptor fusions and HRAS mutations/11p15 amplification. The presence of genomic alterations characteristic of conventional melanomas (BRAF and NRAS mutations) precludes a diagnosis of a Spitz neoplasm. It is often challenging to distinguish Spitz neoplasms from conventional melanomas with spitzoid morphology on histopathological grounds alone.Methods: We report a series of 70 consecutive melanocytic tumors in which targeted sequencing was indicated to distinguish Spitz from spitzoid neoplasms and to classify Spitz neoplasms along the biological spectrum.Results: Final diagnoses incorporating molecular results included 12 conventional melanomas (nine of which with NRAS mutations), five Spitz melanomas, 35 atypical Spitz tumors, eight Spitz nevi, three melanocytic tumors with a MAP2K1 mutation, and seven desmoplastic Spitz nevi/tumors. There were significant discrepancies between initial diagnoses and final diagnoses after incorporating molecular results in 24 (34%) cases, including nine conventional melanomas favored to be Spitz neoplasms and nine Spitz neoplasms favored to be conventional melanomas.Conclusions: It is often not possible to reliably distinguish Spitz neoplasms from spitzoid melanocytic tumors without identifying their driver genomic alterations. Applying next‐generation sequencing in diagnostically problematic tumors improves diagnostic accuracy.

25 December 2021 in Genes
Verified
Journal Article
Open access
PDF file
PKPeter Kiralyc
Peter Kiralyc
AZAndrej Zupan
Andrej Zupan
AMAlenka Matjasic
Alenka Matjasic
PMPolona Jaki Mekjavic
Polona Jaki Mekjavic
Central serous chorioretinopathy (CSC) is a chorioretinal disease that usually affects the middle-aged population and is characterised by a thickened choroid, retinal pigment epithelium detachment, and subretinal fluid with a tendency towards spontaneous resolution. We investigated 13 single-nucleotide polymorphisms (SNPs) in 50 Slovenian acute CSC patients and 71 healthy controls in Complement Factor H (CFH), Nuclear Receptor Subfamily 3 Group C Member 2 (NR3C2), Cadherin 5 (CDH5) Age-Related Maculopathy Susceptibility 2 (ARMS2), TNF Receptor Superfamily Member 10a (TNFRSF10A), collagen IV alpha 3 (COL4A3) and collagen IV alpha 4 (COL4A4) genes using high-resolution melt analysis. Statistical calculations revealed significant differences in genotype frequencies for CFH rs1329428 (p = 0.042) between investigated groups and an increased risk for CSC in patients with TC (p = 0.040) and TT (p = 0.034) genotype. Genotype–phenotype correlation analysis revealed that CSC patients with CC genotype in CFH rs3753394 showed a higher tendency for spontaneous CSC episode resolution at 3 months from the disease onset (p = 0.0078), which could indicate clinical significance of SNP testing in CSC patients. Bioinformatics analysis of the non-coding polymorphisms showed alterations in transcription factor binding motifs for CFH rs3753394, CDH5 rs7499886 and TNFRSF10A rs13278062. No association of collagen IV polymorphisms with CSC was found in this study.